Cofactor Genomics
Cofactor Genomics Begins Multi-Site Clinical Trial for Immunotherapy Prediction Assay
The multi-center study is evaluating the use of Cofactor's OncoPrism test in predicting head and neck cancer patients' response to immunotherapy with other tumor types to follow.
In Brief This Week: Mobidiag, Gestalt Diagnostics, Cofactor Genomics, and More
Mobidiag announced this week that it has completed a previously announced €10 million ($11.33 million) equity investment from Autobio Diagnostics.